Urologix, Inc. (ULGX) Reports Q4 Loss of $0.08; Guides FY13 Sales
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Price: $0.00 --0%
Financial Fact:
Loss before income taxes: -349K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss before income taxes: -349K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Urologix, Inc. (NASDAQ: ULGX) reported Q4 EPS of ($0.08), versus ($0.09) reported last year. Revenue for the quarter came in at $4.5 million, versus $2.92 million reported last year.
Urologix, Inc. sees FY2013 revenue of $17.5-19.0 million.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
Urologix, Inc. sees FY2013 revenue of $17.5-19.0 million.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
